Euflora_1.png
Euflora_3.png
Euflora_4.png
Euflora_5.png
Euflora_6.png
Euflora_7.png
Euflora_8.png
Euflora_9.png
Euflora_10.png
Euflora_11.png
Euflora_12.png
Euflora_13.png
Euflora_14.png

Euflora

In November 2020, Oregon became the first US state to both decriminalize psilocybin and also legalize it for therapeutic use.

What might it look like if Canada did the same?

The Problem

Psychedelic drugs have shown therapeutic potential for the treatment of mental illnesses in scientific studies. However, because psychedelics are currently illegal in Canada, it's difficult for scientists to conduct these studies.

Project Goals

To encourage a re-examination of opinions and current laws regarding psychedelics by creating a glimpse into a speculative future where psychedelics are viewed differently. To advocate for a different way of thinking about how we treat mental illnesses.

Target Audience

Potential Patients

People experiencing mental illness who are unsatisfied with the treatment they are currently receiving.

 

Healthcare Providers

This category can include family physicians, psychiatrists, psychologists, therapists, social workers, and any other healthcare providers who work with individuals dealing with mental illnesses and who might be interested in psychedelic-assisted psychotherapy.

 

Curious Individuals

Besides targeting those who could benefit from psychedelic therapy and their healthcare providers, this project also aims to inspire and educate those who might have trouble seeing psychedelics as having medical uses.

Competition

Because this is a speculative project, there are currently no legally recognized psilocybin treatment centres in Canada. There is, however, a treatment centre in Toronto that provides patients with ketamine-assisted psychotherapy. The company is called Field Trip Health, and is a big inspiration for this project.

Design Approach

In order to reach the target audiences and fulfill the project goals, the brand was intended to be clean and professional, without looking too medical or corporate.

The designs must instill trust in those who view it, without appearing intimidating. The intention was to create branding for a space that doesn't seem cold or lifeless like a doctor's office might, but feels safe and welcoming.

 

Design Deliverables

Primary Deliverable

Branding for a psilocybin-assisted therapy treatment centre, including brand applications such as business stationery, signage, advertisements, clothing, and other branded merchandise.

Secondary Deliverable

A magazine with information on psychedelics, psilocybin, and psilocybin-assisted therapy intended to educate readers and provide information to potential patients.

This magazine also includes a brief history of psychedelics, personal stories, and an overview of the program offered at the treatment centre.